Strategic alliances are one of the best ways to generate solid commercial structures that will last in time. At ZeClinics, we have made this point very clear from the beginning. That is why it is our pride to introduce you Cobo Scientific, ZeClinics' new business partner in Northern Europe.
Cobo Scientific is offering products and services from leading life science companies within the BioMedical and Drug Discovery field. It was founded in January 2017 and is working as an European commercial partner agent for a selection of leading Life Science companies within the BioMedical Research and Drug Discovery segments. Cobo´s team have more than 20 years experience supporting these segments with innovative and unique products and services.
His headquarters is located in Copenhagen, Denmark, in the center of one of Europe´s most innovative Life Science clusters, where they give support to the major hospitals and universities, more than 150 biotech´s and several of the worlds leading pharma companies.
Strategic alliances are one of the best ways to generate solid commercial structures that will last in time. At ZeClinics, we have made this point very clear from the beginning. That is why it is our pride to introduce you Cobo Scientific, ZeClinics' new business partner in Northern Europe.
Cobo Scientific is offering products and services from leading life science companies within the BioMedical and Drug Discovery field. It was founded in January 2017 and is working as an European commercial partner agent for a selection of leading Life Science companies within the BioMedical Research and Drug Discovery segments. Cobo´s team have more than 20 years experience supporting these segments with innovative and unique products and services.
His headquarters is located in Copenhagen, Denmark, in the center of one of Europe´s most innovative Life Science clusters, where they give support to the major hospitals and universities, more than 150 biotech´s and several of the worlds leading pharma companies.
With this fantastic alliance ZeClinics increases its capacity for action in Europe, guaranteeing its entry into the Danish, Swedish, Norwegian, Finnish and Polish markets in what is sure to be a fruitful relationship.
El equipo de investigadores observó cambios en el...
El gen AtCDF3 promueve una mayor producción de az...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del si...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
